Bristol-Myers Squibb BV (BMS) Netherlands

The headquarters of Bristol-Myers Squibb (B-MS) Netherlands several divisions are located in Woerden.

B-MS is originally an American company and has offices worldwide. B-MS has operated for over 40 years In the Netherlands and is a leader in innovative medicines and health products.

For more information about B-MS International, visit: http://www.bms.com/

Squibb settled in 1967 in The Hague. Bristol-Myers since 1971 in the Netherlands. In 1989 both companies merged and Woerden was chosen as a location for BMS.

B-MS has 35,000 employees worldwide, of which 110 work in the Netherlands.

Global B-MS had 2008 sales of $ 20.6 billion.

In 2008, $ 3.6 billion invested in the development of new drugs (17.4% of revenue in 2007 was 17.0%).

B-MS is represented in the associations Nefarma, Netherlands Association of Innovative Drugs and AmCham, American Chamber of Commerce. Both are active in the field of advocacy for the innovative pharmaceutical industry. Topics include: authorization and reimbursement of new drugs, the funding of medicines and promote a favorable climate for innovation in the Netherlands. For more information about the industry, visit: http://www.nefarma.nl or http://www.amchampc.org
Type: NORMAL
Address: Vijzelmolenlaan 9, 3447 GX, Woerden
Website: http://www.b-ms.nl/
Phone: +31 348574222
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.